High Resolution Discovery Proteomics Reveals Candidate Disease Progression Markers of Alzheimer’s Disease in Human Cerebrospinal Fluid

High Resolution Discovery Proteomics Reveals Candidate Disease Progression Markers of Alzheimer’s Disease in Human Cerebrospinal Fluid

Disease modifying treatments for Alzheimer's disease (AD) constitute a major goal in medicine. Current trends suggest that biomarkers reflective of AD neuropathology and modifiable by treatment would provide supportive evidence for disease modification. Nevertheless, a lack of quantitative tool...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
Main Authors: Ronald C. Hendrickson, Anita Y. H. Lee, Qinghua Song, Andy Liaw, Matt Wiener, Cloud P. Paweletz, Jeffrey L. Seeburger, Jenny Li, Fanyu Meng, Ekaterina G. Deyanova, Matthew T. Mazur, Robert E. Settlage, Xuemei Zhao, Katie Southwick, Yi Du, Dan Holder, Jeffrey R. Sachs, Omar Laterza, Aimée Dallob, Derek L Chappell, Karen Snyder, Vijay Modur, Elizabeth King, Catharine Joachim, Andrey Bondarenko, Mark S. Shearman, Keith A. Soper, A. David Smith, William Z. Potter, Ken S. Koblan, Alan B. Sachs, Nathan A. Yates
פורמט: Artigo
שפה:אנגלית
יצא לאור: 2015
גישה מקוונת:https://doi.org/10.1371/journal.pone.0135365
https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0135365&type=printable
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

אינטרנט

https://doi.org/10.1371/journal.pone.0135365
https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0135365&type=printable

פריטים דומים